Navigation Links
Human Pheromone Sciences Announces Third Quarter Results
Date:11/13/2008

Increase in revenue with reduction in loss for the quarter

SAN JOSE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced results for the third quarter and nine months ended September 30, 2008. For the three month period ending September 30, 2008, net revenues of $262,000 represented a 10% increase from the revenues of $239,000 in the prior year period, and resulted in a net loss of $30,000 ($.01 per share) as compared with a net loss of $93,000 ($.02 per share) for the same period of 2007. For the nine month period ending September 30, 2008, net revenues of $764,000 were 15% lower than the previous year's $902,000, resulting in a net loss of $181,000 ($0.04 per share) as compared with a net loss of $54,000 ($0.01 per share) in the first nine months of 2007. At September 30, 2008, the Company reflected a cash balance of $1,082,000 compared with $1,437,000 at December 31, 2007, a $355,000 reduction for the nine months of the current year as compared to a decline of $390,000 during the nine months ending September 30, 2007. There was no bank indebtedness at either date.

A spokesperson indicated "the Company was pleased that its cash utilization was only $355,000 for the first nine months of the year, and that net current liquidity (cash, accounts receivable and inventory, less current liabilities excluding current portion of deferred revenue) decreased only $433,000 for the same nine month period. This lower than expected asset utilization was a result of revenues generated under new licensing agreements, and a concerted effort to only invest in programs that are designed to generate additional future revenues."

"However, we still recognize that the marketing plans of our licensees can create unpredicted volatility of our quarterly performance, and this is not an acceptable posture for the Company in the long-term. We will still continue to nurture
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
2. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
4. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
5. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
6. Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
7. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
8. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
9. Human Pheromone Sciences, Inc. - Shareholder Update
10. The human brain minimizes energy expenditure and integrates gravity in to the action plan
11. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the global...a,s patent office is now the world,s leading produ... China trailed Japan,s patent office, the World In...nited States Patent and Trademark Office (USPTO) f...5, WIPO in 2006, and exceeded Japan for the first ...
(Date:11/23/2009)...ov. 23, 2009 In a provocative new study, a Univer...ioxide emissions the major cause of global warmin... collapses or society builds the equivalent of one...unlikely that there will be any substantial near-t...in carbon dioxide emission rates," says the new pa...
(Date:11/23/2009)...promises ultra-fast communication, computation and...on. But trying to use quantum states as carriers o...ow two physicists have shown, mathematically, how ...unication, while keeping the information intact. T...sical Review Letters and highlighted with a Viewp...
(Date:11/23/2009)...GE,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBioPharma...asestablishedNovember27,2009astheex-dividenddatefo...ingfromthesecuritizationtransactioncompletedonNove...oallstockholdersofrecordontherecorddate,December1,...dividendat$1.67pershareofcommonstockforpurposesoft...
Breaking Biology Technology:China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...d CLAREMONT, Calif., June 25 /Xinhua-PRNewswire-Fi...on (OTC Bulletin Board: KWBT),announced that on Ju...Co.,Ltd. (Kiwa Shandong) received approval documen...epublic of China, ratifying Kiwa Shandong to,whole...ng chemical,fertilizers, complex fertilizers and c...
...KET, N.Y., June 25 Lixte,Biotechnology Holdings (...,National Institute of Neurological Disorders and ...) and Lixte Biotechnology Holdings, Inc. extended,...nt (CRADA) to develop,drugs for the treatment of b...as extended through September 2009., Dr. John S. ...
... Mich., June 25 MichBio announced that,Johnson & ...he keynote,speaker for its statewide Expo and Conf... the association for Michigan,s life science indus...e science event attracting,more than 450 attendees...of the most respected professionals in the industr...
Other Biology Technology:Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the People's Republic of China to Wholesale Other Fertilizer Manufacturers Products 2Kiwa Bio-Tech Receives Authorization From the Ministry of Commerce of the People's Republic of China to Wholesale Other Fertilizer Manufacturers Products 3Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 2Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 3Christine Poon Will Keynote MichBio Expo 2Christine Poon Will Keynote MichBio Expo 3
(Date:11/25/2009)... Death Research Laboratory in the University of Ha...prestigious Johnson & Johnson Focused Funding gran...ll damage in Parkinson,s disease. The award, which...innovation and excellence in science, was announce...onth at an event at the Hyatt Regency Hotel in New...
(Date:11/25/2009)...rofessors recently received funding from the Natio...beneficial to understanding the environment. The t...ood, assistant professor in the Department of Biol... separate research projects. , His first project... and Functions from the Leaf to the Landscape," wi...
(Date:11/24/2009)...day named 12 new grant recipients for 2009. The aw...work across a broad spectrum of lupus research. Al... potential to drive scientific discovery to ultima...of systemic lupus. , The 2009 grants go to both ...ation and include interdisciplinary and highly pro...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Advocate Christ Medical Center Redesignated A 26apos 3BMagnet 26apos 3B Hospital the Highest Nursing Honor 57449 1Advocate Christ Medical Center Redesignated A 26apos 3BMagnet 26apos 3B Hospital the Highest Nursing Honor 57449 2Advocate Christ Medical Center Redesignated A 26apos 3BMagnet 26apos 3B Hospital the Highest Nursing Honor 57449 3Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 1Save a Life 3A Join the Kiel Mortgage Marrow thon on September 23 57447 2InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture 57446 1InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture 57446 2
...ct. 25, 2007 -- The genes that make a fruit fly,s ...iconius butterfly found in South and Central Ameri... , Bob Reed, assistant professor of ecology and e...d in making insect eye pigments evolved over time ...nding sheds light on the genetic causes of wing pa...
...ah biologists genetically manipulated nematode wor...ame sex part of a study that shows sexual orienta...ok like girls, but act and think like boys, says J...thor of the new study. The [same-sex attraction] b...dy was published online Thursday, Oct. 25 in Curre...
...ale School of Medicine researchers have received $...wn chromosomes and DNA after damage caused by radi...e National Institutes of Health (NIH) is the next ... the lead researcher, Peter Glazer, M.D., chair of...ogy research program at Yale Cancer Center. , W...
Other Biology News:Scientists alter sexual orientation in worms 2Scientists alter sexual orientation in worms 3Scientists alter sexual orientation in worms 4Yale receives $8.4 million to study DNA repair in cancer cells 2
... Alkaline Phosphatase Conjugation Horseradish P...cein Isothiocyanate Conjugation R. Phycoerythrin ...n Conjugation Alexa Fluor 488 Conjugation Alexa ... Rpe-Alexa Fluor 750 Conjugation Apc-Alexa Fluor...
...de Synthesis , 20 Amino Acid length max , MS-sp... customer for future usage conjugation of peptide ...2 days/each , Pre-immune bleed x1 /each , Im...leed (app. 5 ml) x1 /each , Production bleed (...
Rat TIMP-1 ELISA development Kit, DuoSet from R&D Systems
...ted Capture Antibody: 12 x 8-well strips, 3 plasti... 2X concentrate , Beta Amyloid 1-40 Standard: 1...d Standard Diluent: 3 mL , Primary Antibody: 150...HRP: 30 microL of concentrate , OPD Substrate: 2...
Biology Products: